CLLS Cellectis
- 2.536
- -0.024-0.94%
Cellectis News
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Cellectis SA (CLLS) and Idexx Laboratories (IDXX)
Barclays Remains a Buy on Cellectis SA (CLLS)
Cellectis SA: A Hold Rating Amidst Strategic Partnerships and Pipeline Potential
Hold Rating for Cellectis SA: A Balance of Promising Data and Pending Uncertainties
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)
JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target
Cellectis Analyst Ratings
JonesTrading Sticks to Their Hold Rating for Cellectis SA (CLLS)
Oppenheimer Reiterates Outperform on Cellectis, Maintains $11 Price Target
Cellectis Analyst Ratings
JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target
Cellectis Analyst Ratings
Analysts Conflicted on These Healthcare Names: Cellectis SA (CLLS), Globus Medical (GMED) and Blueprint Medicines (BPMC)
Barclays Issues a Buy Rating on Cellectis SA (CLLS)
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Cellectis SA (CLLS) and Walgreens Boots Alliance (WBA)
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and Microbot Medical (MBOT)
Oppenheimer Adjusts Cellectis Price Target to $13 From $16, Maintains Outperform Rating
Oppenheimer Maintains Outperform on Cellectis, Lowers Price Target to $13
JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target
JMP Securities Sticks to Their Buy Rating for Cellectis SA (CLLS)
Analysis
Price Target
No Data
